牛牛AI助理已提取核心訊息
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by 180 Life Sciences Corp. effective as of February 9, 2024, at 11:00 A.M. The effectiveness of this form indicates that the company has met the necessary SEC requirements to proceed with the registration of its securities for sale to the public. The SEC's notice of effectiveness is a standard procedure for companies looking to issue new shares and is a significant step towards the company's efforts to raise capital through public investment.
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by 180 Life Sciences Corp. effective as of February 9, 2024, at 11:00 A.M. The effectiveness of this form indicates that the company has met the necessary SEC requirements to proceed with the registration of its securities for sale to the public. The SEC's notice of effectiveness is a standard procedure for companies looking to issue new shares and is a significant step towards the company's efforts to raise capital through public investment.
美國證券交易委員會（SEC）宣佈，180 Life Sciences Corp. 提交的S-1表格自2024年2月9日上午11點起生效。該表格的有效性表明該公司已滿足美國證券交易委員會的必要要求，可以註冊向公衆出售的證券。美國證券交易委員會的生效通知是希望發行新股的公司的標準程序，也是該公司朝着通過公共投資籌集資金的努力邁出的重要一步。
美國證券交易委員會（SEC）宣佈，180 Life Sciences Corp. 提交的S-1表格自2024年2月9日上午11點起生效。該表格的有效性表明該公司已滿足美國證券交易委員會的必要要求，可以註冊向公衆出售的證券。美國證券交易委員會的生效通知是希望發行新股的公司的標準程序，也是該公司朝着通過公共投資籌集資金的努力邁出的重要一步。
有用
沒用